Long-Term results of stereotactic body radiation therapy in medically inoperable stage i non-small cell lung cancer

Robert D. Timmerman; Chen Hu; Jeff M. Michalski; Jeffrey C. Bradley; James Galvin; David W. Johnstone; Hak Choy

doi:10.1001/jamaoncol.2018.1258

Long-Term results of stereotactic body radiation therapy in medically inoperable stage i non-small cell lung cancer

Robert D. Timmerman, Chen Hu, Jeff M. Michalski, Jeffrey C. Bradley, James Galvin, David W. Johnstone, Hak Choy

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1287-1288
Number of pages	2
Journal	JAMA Oncology
Volume	4
Issue number	9
DOIs	https://doi.org/10.1001/jamaoncol.2018.1258
State	Published - Sep 2018

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1001/jamaoncol.2018.1258

Cite this

@article{658fba891bed498a98b12655081402b4,

title = "Long-Term results of stereotactic body radiation therapy in medically inoperable stage i non-small cell lung cancer",

author = "Timmerman, {Robert D.} and Chen Hu and Michalski, {Jeff M.} and Bradley, {Jeffrey C.} and James Galvin and Johnstone, {David W.} and Hak Choy",

note = "Funding Information: Funding/Support: This project was supported by grants U10CA21661 (RTOG-Ops-Stat), U10CA180822 (NRG Oncology SDMC), and U10CA180868 (NRG Oncology Operations) from the National Cancer Institute. Role of the Funder/Sponsor: The sponsor initially approved the study concept and the original protocol, required regular updates regarding protocol accrual and data safety monitoring and provided funds to each participating center for each protocol accrual. The sponsor had no role in the collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Additional Contributions: The following individuals contributed substantially to the design, accrual, and/or analysis of the trial: William Straube, PhD (Washington University, St Louis), Andrea Bezjak, MD (Princess Margaret Hospital, Toronto), Robert Barriger, MD (Indiana University, Indianapolis), Gregory Videtic, MD (Cleveland Clinic, Cleveland), Lucien Nedzi, MD (University of Texas Southwestern, Dallas), Maria Werner-Wasik, MD (Thomas Jefferson University, Philadelphia), Yuhchyau Chen, MD, PhD (University of Rochester, Rochester), Ritsuko Komaki, MD (University of Texas MD Anderson Cancer Hospital, Houston), and Rebecca Paulus, BS (NRG Oncology Statistics and Data Management Center, Philadelphia).",

year = "2018",

month = sep,

doi = "10.1001/jamaoncol.2018.1258",

language = "English (US)",

volume = "4",

pages = "1287--1288",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Long-Term results of stereotactic body radiation therapy in medically inoperable stage i non-small cell lung cancer

AU - Timmerman, Robert D.

AU - Hu, Chen

AU - Michalski, Jeff M.

AU - Bradley, Jeffrey C.

AU - Galvin, James

AU - Johnstone, David W.

AU - Choy, Hak

N1 - Funding Information: Funding/Support: This project was supported by grants U10CA21661 (RTOG-Ops-Stat), U10CA180822 (NRG Oncology SDMC), and U10CA180868 (NRG Oncology Operations) from the National Cancer Institute. Role of the Funder/Sponsor: The sponsor initially approved the study concept and the original protocol, required regular updates regarding protocol accrual and data safety monitoring and provided funds to each participating center for each protocol accrual. The sponsor had no role in the collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Additional Contributions: The following individuals contributed substantially to the design, accrual, and/or analysis of the trial: William Straube, PhD (Washington University, St Louis), Andrea Bezjak, MD (Princess Margaret Hospital, Toronto), Robert Barriger, MD (Indiana University, Indianapolis), Gregory Videtic, MD (Cleveland Clinic, Cleveland), Lucien Nedzi, MD (University of Texas Southwestern, Dallas), Maria Werner-Wasik, MD (Thomas Jefferson University, Philadelphia), Yuhchyau Chen, MD, PhD (University of Rochester, Rochester), Ritsuko Komaki, MD (University of Texas MD Anderson Cancer Hospital, Houston), and Rebecca Paulus, BS (NRG Oncology Statistics and Data Management Center, Philadelphia).

PY - 2018/9

Y1 - 2018/9

UR - http://www.scopus.com/inward/record.url?scp=85053299313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053299313&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2018.1258

DO - 10.1001/jamaoncol.2018.1258

M3 - Letter

C2 - 29852036

AN - SCOPUS:85053299313

SN - 2374-2437

VL - 4

SP - 1287

EP - 1288

JO - JAMA Oncology

JF - JAMA Oncology

IS - 9

ER -

Long-Term results of stereotactic body radiation therapy in medically inoperable stage i non-small cell lung cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this